☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
HOOKIPA
HOOKIPA Reports the First Patient Dosing in P-Ib Study of HB-500 to Treat HIV
July 2, 2024
J.P. Morgan Special: Dealmaker 2022 – Top M&A Deal of Roche (Part 01)
January 5, 2023
HOOKIPA and Roche Enter into a License Agreement to Develop HB-700 and Arenaviral Immunotherapies for KRAS-Mutated Cancers
October 21, 2022
HOOKIPA Entered into an Amended and Restated Collaboration and License Agreement with Gilead to Develop Arenaviral Immunotherapies...
February 16, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.